Atezolizumab vs durvalumab for extensive-stage small cell lung cancer in Japan: a real-world comparative analysis of costs and clinical outcomes.
K. Hirano
Akito Hata
Y. Yamanaka
Toshiyuki Sumi
M. Tamiya
Yuki Sato
Yuko Oya
K. Hamai
N. Katakami
K. Iwasaki
Tatsuhiro Uenishi
K. Kokubo
Ataru Igarashi
Medicine